Board Profiles

Mr Thian Chew


Mr Chew has over 25 years' experience in investing, finance and transforming business operations. He is currently Managing Partner at Polar Ventures, a private investment and consulting firm that provides capital, strategic and operating solutions, focusing on small to mid-sized enterprises in Asia.

Mr Chew was previously an Executive Director at Goldman Sachs (Hong Kong and New York), responsible for the firm's proprietary investments, including growth capital, private equity and special situations. Other previous roles include Consultant Project Manager to Morgan Stanley and a number of positions at KPMG across the Asia-Pacific region, including Director at KPMG Consulting (Singapore and Sydney).

Mr Chew holds an MBA from the Wharton School (Palmer Scholar); an MA from the Lauder Institute, University of Pennsylvania; and a Bachelor of Information Systems from Monash University. Mr Chew is an Adjunct Professor at HKUST's MBA program and previously qualified as a chartered accountant.

Craig Newton

Managing Director and Chief Executive Officer

Craig Newton has over 30 years' experience in senior business and operational roles in the medical device, pharmaceutical and biotech sectors, among large companies and small start-ups, with activity in Australasia, Asia and Europe.

His experience encompasses leadership, marketing, operations and project management across diverse therapeutic areas, including oncology, haematology, cell therapies, fertility and cardiovascular disease. Craig has worked at VivaZome Therapeutics, CSL, Serono UK, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals, in roles such as Executive Director, Chief Operating Officer, Sales and Marketing Director and Business Unit Manager. Prior to his appointment as MD, and CEO, Craig was the Chief Operating Officer at Invion from April 2018 to October 2019. Craig has a Science degree and post-graduate qualifications in Management and in Marketing. 

Melanie Farris

Non-Executive Director and Company Secretary

Melanie is an experienced operations, communications and governance professional, with a strong track record in the planning, management and delivery of strategic corporate projects across industries such as life sciences, investment, agriculture, not-for-profit and music marketing.

Melanie's key experience includes project management of confidential and complex business activities, overall company reporting and compliance with regulatory authorities, restructures, IPOs, M&A and shareholder activities, along with corporate policy development for ASX-listed entities.

Melanie's previous roles include positions in the Office of HRH the Prince of Wales, Global Asset Management, Imperial Cancer Research Fund and The Prince's Foundation. Melanie holds a Bachelor of Communication (Public Relations), and a Graduate Diploma in Applied Corporate Governance. She is a Fellow of the Governance Institute of Australia, a Fellow of the Institute of Chartered Secretaries (UK) and a Member of the Australian Institute of Company Directors (MAICD). 

Alan Yamashita

Non-Executive Director

Mr Yamashita is a highly experienced corporate consultant and investment professional, with over 40 years' experience in investment management, investment banking and alternative investment throughout the APAC region.

From 1999 to 2005, Mr Yamashita was President and CEO of Search Investment Group and founding CEO and CIO of Search Alternative Investment Ltd (SAIL), a major private global hedge fund and private equity investment practice headquartered in Asia.

Prior to Search Investments Group, Mr Yamashita was Managing Director and Head of Asia Capital Markets for Merrill Lynch from 1996 to 1998.

Mr Yamashita is currently Managing Partner at Polar Ventures and has held numerous positions as a 16-year veteran of Goldman Sachs and an advisor to various companies, including Plantation Timber Partners, Wuhan; Duty Free Shoppers, Asia; TVSN, Shanghai; and Mizuho Alternative Investments LLC.